Cart
sales@molnova.com
2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine
CAS No. 237402-29-8
2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine( 2-[(1E)-(dibenzylhydrazin-1-ylidene)methyl]pyridine )
Catalog No. M28397 CAS No. 237402-29-8
2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 87 | Get Quote |
|
| 5MG | 142 | Get Quote |
|
| 10MG | 214 | Get Quote |
|
| 25MG | 358 | Get Quote |
|
| 50MG | 533 | Get Quote |
|
| 100MG | 761 | Get Quote |
|
| 500MG | 1557 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine
-
NoteResearch use only, not for human use.
-
Brief Description2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine is a chemical compound.
-
Description2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms2-[(1E)-(dibenzylhydrazin-1-ylidene)methyl]pyridine
-
PathwayOthers
-
TargetOther Targets
-
RecptormGluR2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number237402-29-8
-
Formula Weight301.385
-
Molecular FormulaC20H19N3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N(Cc1ccccc1)\N=C\c1ccccn1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mitul A Mehta, et al. Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects. Psychopharmacology (Berl). 2018 Jul;235(7):1875-1886.
molnova catalog
related products
-
Chrysin-7-O-glucuron...
Chrysin-7-O-glucuronide is a natural product?with antioxidant activity.
-
8-Azabicyclo-3.2.1-o...
Reference standards.
-
G280-9
The G280-9 peptide, a common melanoma gp100 epitope restricted by MHC-associated HLA-A2. The G280-9 sequence is unique because it could be recognized by cytotoxic T lymphocytes at very low concentrations, however it shows low total immunogenicity that may be attributable to relatively low affinity of this peptide for the HLA-A2.
